◀ Back to MAPK9

MAPK9 — PTPN22

Text-mined interactions from Literome

Spalinger et al., Gastroenterology 2013 (Crohn Disease) : Loss of PTPN22 increased levels of p38-mitogen activated protein kinase , but reduced phosphorylation of nuclear factor-?B subunits
Zhang et al., Journal of translational medicine 2013 : Mechanistically, PEP-1-CAT inhibited p38 MAPK while activating PI3K/Akt and Erk1/2 signaling pathways, resulting in blockade of Bcl2/Bax/mitochondrial apoptotic pathway